Drug development: innovation or imitation deficit?

Morgan, S G, Cunningham, C and Law, M R (2012) Drug development: innovation or imitation deficit? British Medical Journal, 345 (e5880). ISSN 0959-8138


Light and Lexchin argue that the pharmaceutical innovation crisis is a myth.1 Although they correctly diagnose the issue, the drug approval data provided tell only half of the story. To shed more light on drug development trends, we classified US Food and Drug Administration approvals of new drugs (therapeutic new molecular entities) into one of three mutually exclusive categories: first-of-kind drugs to be approved within chemical or …

More Details

Item Type: Article
Subject Areas: Strategy and Entrepreneurship
Date Deposited: 31 Aug 2017 15:41
Subjects: Research and development
Pharmaceutical industry
Last Modified: 14 Jul 2024 01:58
URI: https://lbsresearch.london.edu/id/eprint/871

Export and Share


Full text not available from this repository.


View details on Dimensions' website

Downloads from LBS Research Online

View details

Actions (login required)

Edit Item Edit Item